Почетна › Рак орофаринкса › Merilend
Kliničke studije za Рак орофаринкса u državi Merilend
10 studija za Рак орофаринкса traži učesnike na lokacijama u državi Merilend.
Gradovi u državi Merilend
Zvanični tekst studije (na engleskom)
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
- University of Maryland/Greenebaum Cancer Center, Baltimore
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT05172245A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
- Maryland Proton Treatment Center, Baltimore
- University of Maryland Greenebaum Cancer Center, Baltimore
- Central Maryland Radiation Oncology, Columbia
- и још 1
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07418034E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
- National Institutes of Health Clinical Center, Bethesda
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT05686226Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer
- National Institutes of Health Clinical Center, Bethesda
Тражи се учесникФаза 2
Узраст од 18 до 120 · Оба пола · Ажурирано 19. 10. 2026. · NCT06223568A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
- University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore
- Greater Baltimore Medical Center, Baltimore
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07768189Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- Greater Baltimore Medical Center, Baltimore
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT06532279Integrated Cancer Repository for Cancer Research
- Northwest Hospital, Randallstown
- William E. Kahlert Regional Cancer Center, Westminster
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 19 до 110 · Оба пола · Ажурирано 29. 6. 2026. · NCT02012699Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
- Johns Hopkins Hospital East Baltimore, Baltimore
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 23. 4. 2026. · NCT07209189Treatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy
- Medstar Southern Maryland Hospital Center, Clinton
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 17. 4. 2026. · NCT06902623Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)
- Maryland Proton Treatment Center, Baltimore
- University of Maryland Greenebaum Cancer Center, Baltimore
- Upper Chesapeake Health, Bel Air
- и још 2
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2025. · NCT06088381Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.